Literature DB >> 1322955

A VP4 sequence highly conserved in human rotavirus strain AU-1 and feline rotavirus strain FRV-1.

Y Isegawa1, O Nakagomi, T Nakagomi, S Ueda.   

Abstract

The primary amino acid sequence of the VP4 proteins of human rotavirus strain AU-1 and feline rotavirus strain FRV-1 was deduced from nucleotide sequence analysis of full-length genome segment 4 cDNAs produced by a combined reverse transcription-polymerase chain reaction. The VP4 genes were 2359 nucleotides in length and contained one long open reading frame capable of encoding a protein of 775 amino acids. Strain AU-1 and FRV-1 VP4s were 98.8% similar at both the nucleotide sequence and amino acid level. Given that most of the genome segments of strains AU-1 and FRV-1 formed hybrids under stringent hybridization conditions, the relationship between their VP4 gene sequences is best explained by feline rotavirus being transmitted to human hosts as whole virions relatively recently. Of added interest is that AU-1 and FRV-1 VP4 both exhibit high degrees of similarity (96.0% nucleotide identity and 97.2 to 97.5% amino acid identity) with serotype G1 human rotavirus strain K8 VP4, which is distinct from any other sequenced VP4 allele. This suggests that strain K8 VP4 was derived by natural gene reassortment from a feline rotavirus or a strain AU-1-like human rotavirus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322955     DOI: 10.1099/0022-1317-73-8-1939

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

2.  Sequence conservation within neutralization epitope regions of VP7 and VP4 proteins of human serotype G4 rotavirus isolates.

Authors:  E A Palombo; R F Bishop; R G Cotton
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Nucleotide sequence and expression in E. coli of the complete P4 type VP4 from a G2 serotype human rotavirus.

Authors:  N P Mahajan; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  G3P2 rotaviruses causing diarrhoeal disease in neonates differ in VP4, VP7 and NSP4 sequence from G3P2 strains causing asymptomatic neonatal infection.

Authors:  C D Kirkwood; B S Coulson; R F Bishop
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  VP4 typing of bovine and porcine group A rotaviruses by PCR.

Authors:  V Gouvea; N Santos; M do C Timenetsky
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

6.  Distribution of both rotavirus VP4 genotypes and VP7 serotypes among hospitalized and nonhospitalized Israeli children.

Authors:  I Silberstein; L M Shulman; E Mendelson; I Shif
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Whole genome sequence and phylogenetic analyses reveal human rotavirus G3P[3] strains Ro1845 and HCR3A are examples of direct virion transmission of canine/feline rotaviruses to humans.

Authors:  Takeshi Tsugawa; Yasutaka Hoshino
Journal:  Virology       Date:  2008-09-11       Impact factor: 3.616

9.  Relative frequency of VP4 gene alleles among human rotaviruses recovered over a 10-year period (1982-1991) from Japanese children with diarrhea.

Authors:  S Gunasena; O Nakagomi; Y Isegawa; E Kaga; T Nakagomi; A D Steele; J Flores; S Ueda
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Rotaviruses belonging to the AU-1 genogroup recovered from Israeli infants with diarrhea.

Authors:  I Shif; M Iizuka; I Silberstein; E Mendelson; O Nakagomi
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.